EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bavarian Nordic AS's Enterprise Value is €1,612.3 Mil.
Bavarian Nordic AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €175.3 Mil. Therefore, Bavarian Nordic AS's EV-to-FCF for today is 9.20.
The historical rank and industry rank for Bavarian Nordic AS's EV-to-FCF or its related term are showing as below:
STU:BV3'
s EV-to-FCF Range Over the Past 10 Years
Min: -121.92 Med: -5.34 Max: 84.64
Current: 9.24
During the past 13 years, the highest EV-to-FCF of Bavarian Nordic AS was 84.64. The lowest was -121.92. And the median was -5.34.
STU:BV3's EV-to-FCF is ranked better than 61.82% of 330
companies
in the Biotechnology industry
Industry Median: 16.33
vs STU:BV3: 9.24
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bavarian Nordic AS (STU:BV3) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bavarian Nordic AS's PE Ratio (TTM) for today is calculated as:
Bavarian Nordic AS's share price for today is €25.00.
Bavarian Nordic AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.024.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bavarian Nordic AS EV-to-FCF Related Terms
Bavarian Nordic AS EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bavarian Nordic AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's EV-to-FCF falls into.
Bavarian Nordic AS's current Enterprise Value is €1,612.3 Mil.
Bavarian Nordic AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €175.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bavarian Nordic AS (STU:BV3) has a EV-to-FCF of 9.20 as of Jul. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bavarian Nordic AS and its competitors. According to the industry distribution chart, Bavarian Nordic AS ranks #126 out of 330 companies in the Biotechnology industry, placing it in the top 38.2%.
Is Bavarian Nordic AS's EV-to-FCF too high?
Bavarian Nordic AS's current EV-to-FCF is 9.20. The Biotechnology industry median EV-to-FCF is 16.33. Bavarian Nordic AS's value of 9.20 is 43.7% below this industry median. Based on the distribution chart, Bavarian Nordic AS ranks #126 out of 330 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bavarian Nordic AS has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #126 out of 330 companies for EV-to-FCF. This puts Bavarian Nordic AS in the upper half of its industry. The industry median EV-to-FCF is 16.33. Bavarian Nordic AS's value of 9.20 is 43.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.33, based on 330 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bavarian Nordic AS's current EV-to-FCF of 9.20 is 43.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bavarian Nordic AS and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current EV-to-FCF is 9.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (STU:BV3) is currently considered Modestly Overvalued. The stock's GF Value™ is €21.77, compared to a current price of €25.00 — trading 14.8% above its estimated fair value. The current EV-to-FCF is 9.20 and 43.7% below the Biotechnology industry median of 16.33. Bavarian Nordic AS's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bavarian Nordic AS (STU:BV3), the current EV-to-FCF is 9.20 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (STU:BV3) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of €25.00 is trading 14.8% above its estimated GF Value™ of €21.77.
GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.
Key valuation signals for STU:BV3:
EV-to-FCF: 9.20
GF Value™: €21.77 vs. price of €25.00 (14.8% above fair value)
Industry Position: 43.7% below the Biotechnology median (#126 of 330)
No single metric tells the full story. See the STU:BV3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
82GF Score
Get the complete analysis for STU:BV3
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BV3 has been successfully added to your 
